Abstract:Background: Human embryonic stem cells have two different X chromosome inactivation patterns: skewed X chromosome inactivation and random X chromosome inactivation. Whether there is any difference in copy number variation between those cells is not clear. Objective: To analyze the copy number variation in human embryonic stem cells with skewed X chromosome inactivation at whole genome level, and to analyze the effect of copy number variation on the function of human embryonic stem cells with skewed X chromosome inactivation. Methods: Three skewed X chromosome inactivation cell strains were included in the research group, and two random skewed X chromosome inactivation cell strains were included in the control group. The copy number variation was analyzed with Cytogenetics Whole-Genome 2.7M array produced by Affymetrix, USA. The data were analyzed using ChAS software and OMIM software. The same copy number variation regions and genes were found in the three skewed X chromosome inactivation cell strains. Results and Conclusion: More than 130 copy number variation (> 50 kb) were found in the research group, which was higher than that of 36 copy number variation in the control group, the changes of copy number variation in the two groups were mainly repeated (> 70%). Nine gain copy number variation regions were found in the research group, distributed on 1q22, 1p34.1, 6q16.3, 7q31.32, 11q13.1, 16q12.2, 19p13.12, Xp22.33 and Xq26.2, respectively, all were repeated for three copy number variation. Nineteen genes were found within those copy number variation. All of those above copy number variation regions and genes in the control group were normal two copies. Genes within the copy number variation were closely related to the function of binding of DNA and nucleotide. GPC3 gene mutation on the Xq26.2 was found to be correlated with the skewed X chromosome inactivation. Micro-genomic variation in human embryonic stem cells with skewed X chromosome inactivation was higher than that in the random skewed X chromosome inactivation human embryonic stem cells. Key genes within copy number variation may have disadvantage to the function of human embryonic stem cells.

High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity

Evaluation of human embryonic stem cells and their differentiated fibroblastic progenies as cellular models for in vitro genotoxicity screening.

Human Embryonic Stem Cells May Display Higher Resistance to Genotoxic Stress As Compared to Primary Explanted Somatic Cells.

De Novo Cancer Mutations Frequently Associate with Recurrent Chromosomal Abnormalities during Long-Term Human Pluripotent Stem Cell Culture

Computer and Statistical Analysis of Transcription Factor Binding and Chromatin Modifications by ChIP-seq Data in Embryonic Stem Cell

Screening Ethnically Diverse Human Embryonic Stem Cells Identifies a Chromosome 20 Minimal Amplicon Conferring Growth Advantage

[Progress in the Derivation, Culture of Human Embryonic Stem Cells].

Derivation, Characterization and Differentiation of a New Human Embryonic Stem Cell Line from a Chinese Hatched Blastocyst Assisted by a Non-Contact Laser System

Tumor Progression of Culture‐adapted Human Embryonic Stem Cells During Long‐term Culture

Comparable frequencies of coding mutations and loss of imprinting in human pluripotent cells derived by nuclear transfer and defined factors.

The impact of culture on epigenetic properties of pluripotent stem cells and pre-implantation embryos

Limitations of gene editing assessments in human preimplantation embryos

Reprogramme-induced genomic stability

Aneuploidy in Pluripotent Stem Cells and Implications for Cancerous Transformation

Abnormalities in Human Pluripotent Cells Due to Reprogramming Mechanisms

Copy number variation in human embryonic stem cells with skewed X chromosome inactivation

Non-colony type monolayer culture of human embryonic stem cells

Intact Cell Mass Spectrometry as a Quality Control Tool for Revealing Minute Phenotypic Changes of Cultured Human Embryonic Stem Cells

Culture‐acquired genetic variation in human pluripotent stem cells: Twenty years on

Differences Between Karyotypically Normal and Abnormal Human Embryonic Stem Cells